F Ultragenyx Pharmaceutical Inc. Transaction History
F
- $2.27 Billion
- Q2 2025
A detailed history of F transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, F holds 59,102 shares of RARE stock, worth $2.08 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
59,102
Previous 58,314
1.35%
Holding current value
$2.08 Million
Previous $2.11 Million
1.75%
% of portfolio
0.09%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
362Shares Held
88.2MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$359 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$197 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$139 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$102 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$97.5 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.46B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...